Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To Evaluate the Local Pharmacokinetic Characteristics of Single Administration of Germinal Peptide Eye Drops in Healthy Volunteers in a Phase I Clinical Study

Next Previous
Trial Profile

To Evaluate the Local Pharmacokinetic Characteristics of Single Administration of Germinal Peptide Eye Drops in Healthy Volunteers in a Phase I Clinical Study

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 20 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Timbetasin (Primary)
  • Indications Corneal disorders
  • Focus Pharmacokinetics
  • Sponsors Zhaoke Pharmaceutical (Hefei)

Most Recent Events

  • 16 Sep 2021 Status changed from not yet recruiting to completed.
  • 31 Jan 2020 Planned End Date changed from 27 Feb 2020 to 27 Jul 2020.
  • 31 Jan 2020 Planned primary completion date changed from 30 Dec 2019 to 30 Jun 2019.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top